During the height of the COVID-19 pandemic, the University of Tennessee Research Foundation was hard at work facilitating relationships to connect groundbreaking research from University of Tennessee campuses and institutes with industry need. At the University of Tennessee Health Science Center in Memphis, UTRF entered into a hybrid agreement with Moderna to leverage technology, expertise… Read More
UTHSC researcher developing vaccine to help eradicate rheumatic heart disease, saving thousands of lives each year. Anyone who has spent time around children is likely familiar with strep throat, a common bacterial infection treated with antibiotics in high-income countries. However, in low-to-moderate-income parts of the world, this seemingly innocuous infection can become deadly due to… Read More
Gastrointestinal impairment (GII) is acute paralysis of the GI tract beginning two to seven days after major abdominal surgery. Around 25 percent of patients develop GII due to postoperative ileus (POI), a small bowel blockage or another postoperative complication. GII puts patients at risk and leads to readmission rates exceeding 20 percent following surgery. One… Read More
